公众号 / 文章中毒与环境急症

我们需要标准化的北美乙酰半胱氨酸给药方案来治疗对乙酰氨基酚中毒

We need a standardized North American acetylcysteine dosing regimen for the treatment of paracetamol (acetaminophen) poisoning.
PubMed 文献 · Clin Toxicol (Phila) · 2026-01-29
一句话结论北美临床毒理学四学会专家组未能就具体乙酰半胱氨酸方案达成共识,作者认为两袋方案较一袋两步法更安全。

本文讨论对乙酰氨基酚中毒的乙酰半胱氨酸给药方案。Prescott 等人在 1970 年代引入的三袋方案成为数十年标准治疗,其疗效被接受但存在低发病率不良反应和剂量错误风险。两袋方案和一线两袋两步方案被开发以减轻原方案缺点。一袋两步方案若未在第二步将输注速率降低十倍,有乙酰半胱氨酸过量风险,可导致脑病、昏迷、癫痫、脑水肿和颅内压升高,预后差且常致命。作者认为两袋方案是更安全的选择,并呼吁北美四家临床毒理学学会委托专家组推荐具体方案。

要点

  • Prescott 等人 1970 年代引入的三袋方案成为数十年标准治疗,疗效被接受,但存在低发病率不良反应和剂量错误风险。
  • 一袋两步方案需在第二步将输注速率降低十倍;若未执行该步骤,有乙酰半胱氨酸过量风险,可导致脑病,表现为昏迷、癫痫、脑水肿和颅内压升高,预后差且常致命。
  • 三袋和两袋方案均为单位剂量溶液,旨在完全输注,可防止一袋两步方案中导致医源性死亡的特定错误。
  • 两袋方案需制备两种按患者体重个体化的溶液并依次完全输注,采用单位剂量给药这一药物治疗的核心安全原则。
  • 作者指出,近期系统评价与 Meta 分析、缺乏已发表数据显示一袋两步方案优于两袋方案、以及一袋两步方案的特殊危害,均支持采用两袋方案。

适用人群与场景

  • 对乙酰氨基酚(扑热息痛)中毒患者,需接受乙酰半胱氨酸治疗。

处置流程与药物剂量

  • 三袋方案:Prescott 等人 1970 年代引入的原始方案,成为数十年标准治疗。
  • 两袋方案:需制备两种按患者体重个体化的溶液,依次且完全输注。
  • 一袋两步方案:制备大容量标准化浓乙酰半胱氨酸溶液作为储液,支持初始和维持输注;转为维持时需将输注速率降低十倍(第二步)。
  • 智能泵可编程触发第二步以解决一袋两步方案的速率转换问题,但并非普遍可用,尤其在小乡村医院和偏远隔离社区的非医师配置机构。

红旗征与不能漏的情况

  • 一袋两步方案未执行第二步(将输注速率降低十倍)可导致乙酰半胱氨酸过量,引起脑病,表现为昏迷、癫痫、脑水肿和颅内压升高,预后差且常致命。
  • 一袋两步方案的这一特定错误是医源性死亡的根源,已导致重复死亡。

研究设计与关键结果

  • 本文为综述/观点文章,无原始研究数据。
  • 北美四家临床毒理学学会的专家组发布了治疗对乙酰氨基酚中毒的指南,但未能就具体乙酰半胱氨酸方案达成共识。
  • 乙酰半胱氨酸过量不常见,但具有临床显著的发病率和死亡率;大多数死亡由特殊的剂量或给药错误导致。
  • 一袋两步方案存在已导致重复死亡的缺点,使两袋方案成为更安全的选择。

证据类型、等级与局限

  • 证据类型:综述/专家观点文章。
  • 作者引用近期系统评价与 Meta 分析、缺乏已发表数据显示一袋两步方案优于两袋方案、以及一袋两步方案的特殊危害,支持采用两袋方案。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,两袋方案是更安全的选择,因其采用单位剂量给药,可防止一袋两步方案中因未降低输注速率而导致的乙酰半胱氨酸过量及相关脑病死亡。
  • 作者指出,需要北美乙酰半胱氨酸方案,北美四家临床毒理学学会应委托专家组推荐具体给药方案。
  • 作者指出,智能泵并非普遍可用,尤其在小乡村医院和偏远隔离社区的非医师配置机构。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

INTRODUCTION: Acetylcysteine is the antidote for paracetamol (acetaminophen) poisoning. Prescott and colleagues introduced it in the 1970s as a three-infusion regimen. This regimen became standard care for several decades. Its efficacy is accepted, though its use is associated with low morbidity adverse effects that interrupt patient care. The complexity of the regimen is a source for dosing errors. These issues have spurred the development of multiple new regimens. Recently, an expert panel of the four North American clinical toxicology societies published a guideline for the treatment of paracetamol (acetaminophen) poisoning. They were unable to achieve consensus for a specific acetylcysteine regimen.

TWO-BAG VERSUS ONE-BAG TWO-STEP REGIMENS: Acetylcysteine intravenous regimens are classified as three-bag (the original regimen described by Prescott and colleagues), two-bag, and one-bag two-step. The latter two were developed to mitigate the shortcomings of the original regimen of Prescott and colleagues. The two-bag regimen requires the preparation of two unique patient weight-based solutions intended to be sequentially and completely infused. The one-bag two-step regimen consists of the preparation of a large volume of a standardized concentrated acetylcysteine solution. It serves as a reservoir intended to support both the initial and maintenance infusions. Shift to maintenance requires a ten-fold decrease in the infusion rate (the second step). The two-bag regimen employs unit-dose drug administration, a cardinal safety principle of drug therapy. It prevents overdose of the prescribed drug.

UNIQUE RISK OF THE ONE-BAG TWO-STEP REGIMEN: Failure to decrease the rate of infusion, the second step of the one-bag two-step regimen, risks overdose of acetylcysteine, which can produce encephalopathy. Features include coma, seizures, cerebral edema, and increased intracranial pressure. The prognosis is poor and often fatal. The three and two-bag regimens consist of unit-dose solutions intended to be completely infused. This prevents this specific error, which is the root cause of iatrogenic deaths due to the one-bag two-step regimen. Smart pumps programmed to trigger the second step address this issue. However, they are not universally available. This is particularly so in resource-challenged medical environments such as small rural hospitals and non-physician staffed facilities in remote, isolated communities.

DISCUSSION: There is a need for a North American acetylcysteine regimen as recommended by the Institute for Safe Medication Practices. This would support prompt and safe care by front-line providers by diminishing uncertainty, confusion, and the risk for medical error. Acetylcysteine overdose is uncommon but has clinically significant morbidity and mortality. Most deaths are due to unique dosing or administration errors. However, the one-bag two-step regimen has a shortcoming that has resulted in repeat deaths, thus making the two-bag regimen a safer choice.

THE WAY FORWARD: There is a need for a North American acetylcysteine regimen. The four North American clinical toxicology societies should commission an expert panel with the mandate to recommend a specific acetylcysteine dosing regimen for the treatment of paracetamol (acetaminophen) poisoning. The recent systematic review and meta-analysis, the lack of published data showing the advantage of the one-bag two-step regimen over the two-bag approach, and its unique hazard support a two-bag regimen.

来源:Clin Toxicol (Phila),查看原文。版权归原作者所有。

参考来源

  1. Tenenbein M. We need a standardized North American acetylcysteine dosing regimen for the treatment of paracetamol (acetaminophen) poisoning. Clin Toxicol (Phila). 2026. PMID: 41608767. doi:10.1080/15563650.2025.2571457

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。